Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China flag China · Delayed Price · Currency is CNY
10.78
-0.08 (-0.74%)
Apr 28, 2026, 3:04 PM CST

SHE:002399 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
14,47215,73514,15215,34517,09022,787
Market Cap Growth
-5.70%11.19%-7.78%-10.21%-25.00%-3.74%
Enterprise Value
14,66515,79115,45619,08319,99224,281
Last Close Price
10.8611.7910.4711.4912.4716.56
PE Ratio
45.5945.0221.88-23.4994.63
Forward PE
19.3918.6420.6624.0614.6431.09
PS Ratio
2.642.872.682.832.393.58
PB Ratio
1.201.301.161.281.381.98
P/TBV Ratio
1.541.671.511.661.812.62
P/FCF Ratio
9.099.897.11---
P/OCF Ratio
8.459.196.4538.53--
EV/Sales Ratio
2.682.882.933.512.793.82
EV/EBITDA Ratio
15.9117.7915.00180.7015.7122.01
EV/EBIT Ratio
25.8527.8421.09-20.0229.13
EV/FCF Ratio
9.219.927.76---
Debt / Equity Ratio
0.250.250.290.460.520.49
Debt / EBITDA Ratio
3.233.233.3338.644.954.98
Debt / FCF Ratio
1.871.871.78---
Net Debt / Equity Ratio
0.010.010.080.270.240.15
Net Debt / EBITDA Ratio
0.160.160.9630.082.371.57
Net Debt / FCF Ratio
0.090.090.50-81.01-3.08-8.62
Asset Turnover
0.320.320.290.270.360.33
Inventory Turnover
0.770.770.590.670.841.11
Quick Ratio
1.141.141.100.760.941.19
Current Ratio
2.322.322.602.132.222.25
Return on Equity (ROE)
2.82%2.82%5.17%-6.58%5.97%2.01%
Return on Assets (ROA)
2.09%2.09%2.51%-0.68%3.13%2.73%
Return on Invested Capital (ROIC)
3.92%3.80%4.45%-1.42%6.00%6.18%
Return on Capital Employed (ROCE)
4.50%4.50%5.40%-1.50%6.60%5.80%
Earnings Yield
2.41%2.22%4.57%-5.10%4.26%1.06%
FCF Yield
11.00%10.12%14.07%-0.26%-5.73%-0.88%
Dividend Yield
1.34%1.23%2.39%-0.80%0.21%
Payout Ratio
123.27%123.27%24.72%-34.51%171.31%
Buyback Yield / Dilution
-0.00%0.72%-0.67%-0.05%-8.42%
Total Shareholder Return
1.33%1.23%3.11%-0.67%0.75%-8.21%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.